Search clinical trials for: Intravenous bortezomib
Total 7350 results
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedTumors | Non-Hodgkins's LymphomaUnited States
-
Masonic Cancer Center, University of MinnesotaMillennium Pharmaceuticals, Inc.TerminatedLymphoproliferative DisorderUnited States
-
Gruppo Italiano Studio LinfomiCompletedNon Hodgkin's Follicular LymphomaItaly
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMultiple Myeloma | Chronic Myeloid Leukemia (CML) | Pancreatic Ca | Colon/Rectal Ca | Carcinoma, Non-Small -Cell LungUnited States
-
University of ArkansasNational Institutes of Health (NIH)CompletedMultiple MyelomaUnited States
-
Yonsei UniversityUnknownMultiple Myeloma Patients Who Candidate for Autologous Peripheral Blood Stem Cell TransplantationKorea, Republic of
-
Mayo ClinicMillennium Pharmaceuticals, Inc.CompletedKidney TransplantationUnited States
-
Chinese University of Hong KongShanghai Children's Medical CenterCompletedAcute Lymphoblastic Leukemia, in RelapseHong Kong
-
Hamid SayarBayer; Merck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.Completed
-
University of Southern CaliforniaUnknownRenal Cell CancerUnited States
-
Weill Medical College of Cornell UniversityPfizer; Millennium Pharmaceuticals, Inc.TerminatedMantle Cell LymphomaUnited States
-
New Mexico Cancer Care AllianceTerminatedMetastatic Renal Cell CarcinomaUnited States
-
Royan InstituteCompletedChronic Kidney DiseaseIran, Islamic Republic of
-
University Hospital HeidelbergGerman Cancer Research Center; Janssen-Cilag International NV; inVentiv Health... and other collaboratorsCompleted
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
University Hospital, Basel, SwitzerlandTerminatedDysferlinopathySwitzerland
-
University of UtahTerminatedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Mongi Slim HospitalCompletedArthroplasty, Replacement, Knee | Blood Transfusion | Arthroplasty, Replacement, Hip | Tranexamic AcidTunisia
-
Milton S. Hershey Medical CenterUnknownMantle Cell LymphomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedMelanoma | Solid Tumor | Brain and Central Nervous System TumorsUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
Northwestern UniversityRobert H. Lurie Cancer CenterCompletedNon-Hodgkin's LymphomaUnited States
-
NanoAlvandCompletedMultiple Myeloma, Refractory
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Janssen-Cilag G.m.b.HCompletedMultiple MyelomaGermany
-
M.D. Anderson Cancer CenterCompletedMultiple MyelomaUnited States
-
Groupe Francophone des MyelodysplasiesUnknownMyelodysplastic SyndromesFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Terminated
-
Rasim GucalpMillennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
AHS Cancer Control AlbertaAbbott; Tom Baker Cancer CentreCompleted
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedChronic Graft Versus Host DiseaseUnited States
-
Masonic Cancer Center, University of MinnesotaMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.TerminatedLeukemia | Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Neuroblastoma | WilmsTumorUnited States
-
Duke UniversitySpectrum Pharmaceuticals, IncTerminated
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
GlaxoSmithKlineWithdrawn
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
Hospital General de MexicoRecruitingAcute Lymphoblastic Leukemia, in Relapse | Chemotherapeutic Toxicity | Minimal Residual DiseaseMexico
-
Shahid Beheshti University of Medical SciencesRecruitingAntibody-mediated RejectionIran, Islamic Republic of
-
Beijing Chao Yang HospitalEnrolling by invitationMultiple Myeloma | BortezomibChina
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedGraft-versus-Host DiseaseUnited States
-
PETHEMA FoundationCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedLymphoma | Mantle Cell Lymphoma | Indolent Lymphoma | SLLUnited States
-
University of MinnesotaCompleted
-
SCRI Development Innovations, LLCNovartisTerminated
-
University of ChicagoNational Cancer Institute (NCI)Completed